Can Genetic and Epigenetic Therapies Influence Tissue Health?
Emerging therapies targeting genetic and epigenetic modifications hold promise for treating various diseases. Gene therapy aims to correct defective genes, while epigenetic therapies seek to modify aberrant epigenetic marks. For example, DNA methyltransferase inhibitors and histone deacetylase inhibitors are being explored as treatments for cancer. These therapies have the potential to restore normal gene expression and improve tissue health.
